Jack R. Lazar - 25 Jan 2022 Form 4 Insider Report for Casper Sleep Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Jan 2022, 15:17:30 UTC
Prior SEC filing
18 Nov 2021
Next SEC filing
16 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Monahan, Attorney-in-Fact for Jack Lazar

Key filing fact

Jack R. Lazar filed Form 4 for Casper Sleep Inc. on 26 Jan 2022.

Key facts

  • This page summarizes Jack R. Lazar's Form 4 filing for Casper Sleep Inc..
  • 5 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 26 Jan 2022, 15:17.

Change

  • Previous filing in this sequence was filed on 18 Nov 2021.
  • Current net transaction value: -$345,414.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSPR transaction

Common Stock

Disposed to Issuer

Transaction value
$345,414
Shares
-50,060
Change %
-100%
Price
$6.90
Shares after
0
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSPR transaction Derivative

Stock Option

Disposed to Issuer

Transaction value
$0
Shares
-1,517
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,517
Exercise price
$15.90
Footnotes
F3, F4
CSPR transaction Derivative

Stock Option

Disposed to Issuer

Transaction value
$0
Shares
-2,260
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,260
Exercise price
$15.33
Footnotes
F3, F4
CSPR transaction Derivative

Stock Option

Disposed to Issuer

Transaction value
$0
Shares
-3,222
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,222
Exercise price
$15.90
Footnotes
F3, F4
CSPR transaction Derivative

Stock Option

Disposed to Issuer

Transaction value
$0
Shares
-60,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60,000
Exercise price
$15.90
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jack R. Lazar is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.

Footnote F2

In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.

Footnote F3

The options were fully vested and exercisable.

Footnote F4

In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.

Footnote F5

The options provided for vesting in equal monthly installments over a four year period commencing on May 12, 2019, and would have been fully vested and exercisable on April 12, 2023.

SEC remarks

Exhibit 24 - Power of Attorney.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .